发明名称 COMBINATIONS COMPRISING A GLUCOCORTICOID RECEPTOR MODULATOR FOR THE TREATMENT OF RESPIRATORY DISEASES
摘要 <p>The invention provides a pharmaceutical product, kit or composition comprising a first active ingredient which is a glucocorticoid receptor modulator and a second active ingredient selected from an Adenosine A2A receptor antagonist, an anti-infective, an antioxidant, a ß2 adrenoceptor agonist, a CCR1 antagonist, a chemokine antagonist, a muscarinic antagonist, a glucocorticosteroid, a CRTh2 antagonist, a DP1 antagonist, a formyl peptide receptor antagonist, a Histone Deacetylase activator, a chloride channel hCLCA1 blocker, an Epithelial sodium channel blocker, an Inter-cellular adhesion molecule 1 blocker, an IKK2 kinase inhibitor, a JNK kinase inhibitor, a COX inhibitor, a lipoxygenase inhibitor, a leukotriene receptor antagonist, a MEK-1 kinase inhibitor, a MPO inhibitor, a PDE4, inhibitor, a PI 3 kinase ? inhibitor, a PPAR? agonist, a protease inhibitor, a p38 inhibitor, a RAR? modulator, a statin, a thromboxane antagonist and a vasodilator; and its use in the treatment of respiratory disease.</p>
申请公布号 WO2011061527(A1) 申请公布日期 2011.05.26
申请号 WO2010GB51905 申请日期 2010.11.16
申请人 ASTRAZENECA AB;BAYER SCHERING PHARMA AG;ASTRAZENECA UK LIMITED;HANSSON, THOMAS;NILSSON, STINABRITT 发明人 HANSSON, THOMAS;NILSSON, STINABRITT
分类号 A61K31/416;A61K31/428;A61K31/438;A61K31/4439;A61K31/4468;A61K31/4965;A61K31/519;A61K31/58;A61K45/06 主分类号 A61K31/416
代理机构 代理人
主权项
地址